Edward Morrow Atkinson III, EVP, Chief Technical Operations Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 14,112 shares at $478.00 ($6.8M) on 2024-06-12, disclosed to the SEC on 2024-06-13.
Scheduled sale ($6.8M) by EVP, Chief Technical Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $481.96 | 6,824 | $3.3M | 48.6% |
| 2 | $478.00 | 7,288 | $3.5M | 51.4% |
| Total | $479.91 avg | 14,112 | $6.8M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-12 | $806K | — | Filing → |
| VRTX | SELL | 2025-11-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $1.3M | — | Filing → |